Similar articles

• Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats.

  Shen FM, Xie HH, Ling G, Xu LP, Su DF. Shen FM, et al. Acta Pharmacol Sin. 2005 Nov;26(11):1303-8. doi: 10.1111/j.1745-7254.2005.00185.x. Acta Pharmacol Sin. 2005. PMID: 16225751
• beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.

  Nikam AP, Bodhankar SL, Piplani P, Bansal J, Thakurdesai PA. Nikam AP, et al. J Pharm Pharmacol. 2008 Nov;60(11):1501-6. doi: 10.1211/jpp/60.11.0011. J Pharm Pharmacol. 2008. PMID: 18957171
• Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.

  Karppanen H, Lahovaara S, Mattila MJ. Karppanen H, et al. Ann Med Exp Biol Fenn. 1973 Mar;51(3):104-11. Ann Med Exp Biol Fenn. 1973. PMID: 4149365 No abstract available.
• The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.

  Harry JD. Harry JD. Postgrad Med J. 1977;53 Suppl 3:65-9. Postgrad Med J. 1977. PMID: 928268 No abstract available.
• [Hypotensive effect of ICI-66082].

  Arce Gómez E, Aguirre Roux L. Arce Gómez E, et al. Prensa Med Mex. 1977 Mar-Apr;42(3-4):187-93. Prensa Med Mex. 1977. PMID: 335383 Clinical Trial. Spanish. No abstract available.